Dermatology Focus Target high-value dermatology and pruritus relief products to Ferndale’s portfolio, emphasizing brand-name dermal pain relief and hemorrhoidal care as core growth drivers.

Therapy Expansion Propose expansion of wound healing, protective skin therapies, and cosmetically oriented dermatology solutions to align with Ferndale’s mission to heal, protect, and beautify the skin.

Surgical Adhesives Leverage Ferndale’s premium surgical adhesive and adhesive remover to explore adjacent markets such as post-procedure care, closure products, and dermatological procedures.

Mid‑Market Targeting With a revenue base of 100–250M and a mid-size employee footprint, position solutions that scale efficiently for growth-stage dermatology manufacturers and private-label opportunities.

Strategic Partnerships Offer collaboration opportunities in product development, regulatory support, and distribution enhancements with other pharma players of similar size to expand market reach and accelerate launches.